Literature DB >> 1741146

Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy.

G N Kervick1, S C Pflugfelder, R Haimovici, H Brown, E Tozman, R Yee.   

Abstract

Six patients with rheumatoid arthritis (eight eyes) presented with small paracentral perforating corneal ulcers in otherwise quiet eyes. Initial management in five patients (seven eyes) consisted of systemic immunosuppression and therapeutic tissue adhesive with a bandage contact lens or tectonic keratoplasty. Ulceration recurred in all of these eyes, and recurrent ulcers treated with repeat tectonic keratoplasty or therapeutic tissue adhesive and a bandage contact lens all developed recurrent ulceration. The introduction of topical cyclosporine therapy in five eyes with recurrent corneal ulceration was associated with arrest of keratolysis and rapid re-epithelialization of the ulcer in all cases. One corneal ulcer was successfully treated initially with topical cyclosporine, tissue adhesive, and a bandage contact lens. In patients with rheumatoid arthritis and small paracentral corneal ulcerations or perforations, application of tissue adhesive and a bandage contact lens and introduction of topical cyclosporine may be the preferred initial treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741146     DOI: 10.1016/s0161-6420(92)32006-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Ophthaproblem. Peripheral corneal thinning secondary to rheumatoid arthritis.

Authors:  J Cheung; S Sharma
Journal:  Can Fam Physician       Date:  2000-09       Impact factor: 3.275

Review 2.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

Review 3.  Topical ciclosporin in the treatment of ocular surface disorders.

Authors:  S Tatlipinar; E K Akpek
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers.

Authors:  J D Gottsch; E K Akpek
Journal:  Trans Am Ophthalmol Soc       Date:  2000

5.  No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis.

Authors:  M McKibbin; B Clark; H Lee; J D Isaacs; H C Gooi; A J Morrell
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

6.  Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995-7.

Authors:  M McKibbin; J D Isaacs; A J Morrell
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

Review 7.  [Diseases of the outer eye in rheumatoid arthritis].

Authors:  E Feist; U Pleyer
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

8.  Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations.

Authors:  J Prada; B Noelle; H Baatz; C Hartmann; U Pleyer
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

9.  Ocular complications of adult rheumatoid arthritis.

Authors:  S C Reddy; U R Rao
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 10.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.